Financial reports
10-Q
2024 Q2
Quarterly report
12 Aug 24
10-Q
2024 Q1
Quarterly report
15 May 24
10-K/A
2023 FY
Annual report (amended)
29 Apr 24
10-K
2023 FY
Annual report
28 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
22 Mar 23
10-Q
2022 Q3
Quarterly report
7 Nov 22
Current reports
8-K
Agile Therapeutics Common Shareholders to receive $1.52 per share of common stock
26 Aug 24
8-K/A
Financial Statements and Exhibits
16 Jul 24
8-K/A
Financial Statements and Exhibits
15 Jul 24
8-K
Entry into a Material Definitive Agreement
26 Jun 24
8-K
Entry into a Material Definitive Agreement
21 May 24
8-K
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
15 May 24
8-K
Results of Operations and Financial Condition
9 Apr 24
8-K
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update
28 Mar 24
8-K
Agile Therapeutics Announces Delisting from Nasdaq
25 Mar 24
8-K
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution
14 Mar 24
Registration and prospectus
15-12G
Securities registration termination
30 Sep 24
RW
Registration withdrawal request
28 Aug 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Aug 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Aug 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Aug 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Aug 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Aug 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Aug 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Aug 24
S-8 POS
Registration of securities for employees (post-effective amendment)
26 Aug 24
Proxies
DEFM14A
Proxy related to merger
25 Jul 24
DEFA14A
Additional proxy soliciting materials
16 Jul 24
PREM14A
Preliminary proxy related to merger
12 Jul 24
DEFA14A
Additional proxy soliciting materials
26 Jun 24
DEF 14A
Definitive proxy
28 Apr 23
DEF 14A
Definitive proxy
9 Feb 23
PRE 14A
Preliminary proxy
26 Jan 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEF 14A
Definitive proxy
28 Mar 22
Other
EFFECT
Notice of effectiveness
28 Aug 24
EFFECT
Notice of effectiveness
28 Aug 24
EFFECT
Notice of effectiveness
28 Aug 24
EFFECT
Notice of effectiveness
23 May 23
CORRESP
Correspondence with SEC
19 May 23
CORRESP
Correspondence with SEC
19 May 23
UPLOAD
Letter from SEC
19 Apr 23
EFFECT
Notice of effectiveness
5 Jul 22
CORRESP
Correspondence with SEC
29 Jun 22
CORRESP
Correspondence with SEC
29 Jun 22